Forgotten Biliary Plastic Stents: Complications, Management, and Clinical Outcomes
Internal Medicine Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt; mohamedelsebaey79@gmail.com (M.A.E.); m.enaba@hotmail.com (M.E.E.); tamerelbedewy@yahoo.com (T.A.E.); ahmed.elhadedy@med.tanta.edu.eg (A.A.E.); aorta2025@yahoo.com (M.E.S.); dr.waleedelrefaey@gmail.com (W.E.); rasha.hagag@med.tanta.edu.eg (R.Y.H.)
Tropical Medicine Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt; hebae92@gmail.com
Tropical Medicine Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
Gastroenterology Department, King Fahad Specialist Hospital, Buraydah 52366, Saudi Arabia; dr.abdullahmq@gmail.com
Internal Medicine Department, Mansoura New General Hospital, Mansoura 34008, Egypt; assemmelsokkary@gmail.com
Gastroenterology, Hepatology and Infectious Diseases Department, Red Crescent Hospital, Tanta 66232, Egypt; mohamedelabd009@gmail.com
Gastroenterology/Internal Medicine Department, Federal Medical Centre Keffi, Keffi 961101, Nasarawa State, Nigeria; abdulrashid.aoa@gmail.com
Hepatology, Gastroenterology and Infectious Diseases Department, Mahala Hepatology Teaching Hospital, El-Mahalla el-Kubra 31951, Egypt; dryousryaboaamer@hotmail.com (Y.E.-E.A.-A.); ashrafrafat@gmail.com (A.R.A.-E.)
Hepatology, Gastroenterology and Infectious Diseases Department, Ahmed Maher Teaching Hospital, Cairo 11638, Egypt; mashhap8@gmail.com
Internal Medicine Department, National Hepatology and Tropical Medicine Research Institute, Cairo 11638, Egypt; mohamedsaleh20@gmail.com
Tropical Medicine Department, National Hepatology and Tropical Medicine Research Institute, Cairo 11638, Egypt; drhalim2011@gmail.com
Internal Medicine Department, Faculty of Medicine, Cairo University, Giza 12613, Egypt; amroabdelaziz@kasralainy.edu.eg
Abstract
Background and Objectives: Endoscopic biliary plastic stenting is a safe and effective temporary therapeutic modality used in various benign biliary disorders. Long-term indwelling stents for more than one year without retrieval are termed “forgotten biliary stents”. In clinical practice, the forgotten stents are underestimated and the majority of data were obtained from case reports. The aim of this study was to determine the forgotten-biliary-plastic-stent-related complications, their management, and the patients’ clinical outcomes. Materials and Methods: This retrospective study was performed at three hospitals during the period from January 2021 to December 2023. In total, 577 patients with biliary plastic stents—inserted for a variety of benign biliary conditions—were included. They were divided into two groups, as follows: group 1 included 527 patients who had biliary stents removed within 3 months, and group 2 included 50 patients with biliary stents retrieved after one year of their deployment. The stent-related complications (e.g., acute cholangitis, stent clogging, distal stent migration, new common bile duct (CBD) stone formation, and proximal stent migration) and the endoscopic management success rate were evaluated. Results: Irretrievable CBD stones were the main indication for biliary plastic stenting in both groups. The stent-related complications, number of endoscopic sessions, and hospital admissions were significantly higher in the patients with forgotten biliary stents than those with stent removal within 3 months. All the study patients were successfully managed endoscopically with uneventful outcomes. Conclusions: Based on this retrospective study, non-adherence to the endoscopists’ instructions is the main reason for retained biliary stents for more than one year. The patients with forgotten stents had significantly higher complication rates, a higher number of endoscopic sessions, and a higher number of hospital admissions than those with stents that were retrieved in the scheduled time. All patients were managed endoscopically with a technical success rate of 100%, and with no complication-related mortality.
Untitled section
Keywords: forgotten biliary stents, acute cholangitis, stent clogging, stent migration
Article notes
Untitled section
Received 2024 Jun 30; Revised 2024 Jul 24; Accepted 2024 Jul 29; Collection date 2024 Aug.
1. Introduction
Endoscopic retrograde cholangiopancreatography (ERCP) is a complex procedure utilized to investigate and manage various pancreatic–biliary disorders, most commonly for extracting common bile duct (CBD) stones. ERCP entails multiple risks and can lead to major complications [1]. Endoscopic biliary plastic stenting is a well-established and widely accepted modality for the management of different benign biliary disorders such as irretrievable CBD stones, benign biliary strictures, and post-cholecystectomy biliary leaks [2,3]. Biliary plastic stents are indicated when short-term relief of biliary obstruction is intended [4]. Despite their widespread use in clinical practice, being inexpensive and easy to be removed or replaced, biliary plastic stents are prone to clogging a few days or several months later [5,6,7]. Therefore, society guidelines recommend that biliary plastic stents are removed or exchanged within 3 months from the index procedure [8,9]. The patient’s adherence to the stent follow-up scheduled time is vital. Biliary plastic stents retained for more than one year from the index ERCP without retrieval are defined as “forgotten biliary stents”. These forgotten stents can result in major consequences, including acute cholangitis, stent occlusion, proximal and distal migration, and biliary stone and giant stentolith formation [10,11,12]. Acute cholangitis occurs due to biliary blockage that results in bile stasis, infection, and the translocation of the microorganisms or endotoxins from the infected bile into systemic circulation. The diagnostic criteria and severity grading of acute cholangitis were based on the Tokyo guidelines 2018 [13]. To the best of our knowledge, there are few published studies about forgotten biliary plastic stents and most data were obtained from case reports. In clinical practice, the forgotten stents are often overlooked, underestimated, and seldom reported. This retrospective study was conducted to determine forgotten-biliary-plastic-stent-related complications, their management, and the patients’ clinical outcomes.
2. Patients and Methods
2.1. Study Design
This retrospective study was carried out during the period from January 2021 to December 2023 at the Internal Medicine Department of Tanta University Hospital, Ibn Sina Specialized Hospital and American Hospital of Tanta, Egypt. During the study period, 1968 ERCP procedures were performed. Of them, 527 patients had biliary plastic stents removed within 3 months (group 1), and 50 patients had biliary plastic stents retrieved after one year of their deployment (group 2); both groups were included in the present study. The current study was approved by the local research ethical committee of the faculty of medicine, Tanta University, Egypt (approval code: 36264PR292/8/23; approval date: (9 August 2023), and conformed to the ethical principles for medical research of the Helsinki Declaration 1975 and its subsequent amendments (1983).
2.2. Inclusion Criteria
The inclusion criteria were patients aged more than 18 years, with endoscopic biliary plastic stents retrieved within 3 months, or after one year of their deployment. These stents were previously deployed in these patients for different indications including irretrievable CBD stones, post-cholecystectomy biliary leak, Mirizzi syndrome, and benign CBD strictures.
2.3. Exclusion Criteria
Patients with ERCP procedures without biliary plastic stenting, and those with biliary plastic stents retained for a period of more than 3 months and up to 12 months were excluded from this study. Patients with indwelling biliary metal stents and those with malignant biliary obstruction were also ruled out.
2.4. Data Collection
The following data were obtained from the patients’ medical files and were analyzed retrospectively: age, gender, comorbidities, index ERCP findings and plastic stenting indications, type and duration of the deployed stents, presenting clinical features, results of laboratory investigations, and the details of the ERCP procedures for management of the biliary plastic stents and their related complications. The reasons for forgotten biliary stents were obtained by conducting telephone interviews with the patients.
2.5. Endoscopic Management of the Biliary Plastic Stents and Their Related Complications
The endoscopic procedures were performed under deep sedation using intravenous midazolam and propofol. Some patients received intravenous hyoscine N-butylbromide to minimize intestinal perstalsis. All ERCP procedures were carried out using video duodenoscopes (Olympus TJF-Q180V, Tokyo, Japan and Fujifilm ED-530XT, Tokyo, Japan) by experienced endoscopists under fluoroscopic guidance. The therapeutic ERCP procedures were performed as standard of care following guideline recommendations, as follows: Biliary plastic stents in situ were retrieved using a snare or grasper. Proximally migrated biliary stents were pulled down using an extraction balloon or Dormia basket placed over the guidewire, which was advanced alongside the stent. Another technique for stent retrieval was grasping its distal end using a snare or grasper and directly pulling it out. Distally migrated biliary stents were retrieved using a snare or grasper when they were accessible. Inaccessible stents were followed up with abdominal X-ray. For patients with detected CBD stones, their removal was attempted using an extraction balloon or Dormia basket after extending the prior sphincterotomy and/or sphincteroplasty when required. Mechanical lithotripsy was used in the case of difficult stone extraction. If stone removal was incomplete, new plastic stents were inserted [8]. The endoscopic management of the forgotten-biliary-plastic-stent-related complications is demonstrated in Figure 1.
2.6. Definitions
A forgotten biliary stent is defined as having CBD stent placement for more than one year without retrieval. Proximally migrated biliary stents are considered if their distal end is not endoscopically detected at the duodenal papilla and the stent is visible in the biliary tree during fluoroscopic examination. Distal migration is confirmed when the stent is located below its original position or it is not detected on the endoscopic and fluoroscopic examination [14,15].
2.7. Clinical Outcomes
The primary outcomes were the detection of the biliary-plastic-stent-related complications (e.g., acute cholangitis, stent clogging, new stone formation, and proximal and distal biliary stent migration) and the endoscopic management success rate. The secondary outcomes included complications related to mortality, hospital stay, and the number of therapeutic endoscopic sessions (one or more than one session). In the patients who had CBD re-stenting, ERCP was scheduled for further management. The patients with gallbladder stones were referred to surgery.
2.8. Statistical Analysis
The statistical analysis was performed using Statistical Package for the Social Sciences (SPSS, version 24.0. IBM Corp, Armonk, NY, USA). Quantitative data were expressed as mean ± standard deviation (SD). Qualitative data were expressed as frequency and percentage. The following tests were conducted: Independent-samples t-test of significance was used when comparing between two means. Chi-square (X2) test of significance was used in order to compare proportions between two qualitative parameters. p value < 0.05 was considered significant.
3. Results
3.1. Patients’ Characteristics
During the study period, 1968 ERCP procedures were performed. Of them, 527 patients had biliary plastic stents removed within 3 months (group 1), and 50 patients had biliary plastic stents retrieved after one year of their deployment (group 2); both groups were included in the present study. Characteristics of the study patients are shown in Table 1. There were statistically significant differences between the two groups regarding the duration of biliary plastic stenting and presenting symptoms. Meanwhile, there were no significant differences regarding other parameters (e.g., gender, age, and indications of biliary stenting). In the current study, the main indication of the endoscopic biliary plastic stenting was irretrievable CBD stones in 422 patients, 80.08% (group 1), and in 39 patients, 78% (group 2). In group 2, the stents were planned to be removed within 3 months of insertion; however, 30 patients intentionally did not attend their scheduled appointment because of noncompliance with the endoscopist’s instructions. Other patients admitted to unawareness of the stent insertion (6 patients) or the need for its removal (8 patients). There was no apparent reason for the forgotten stents in six patients.
| Parameters | Biliary Plastic Stent Removal (within 3 Months) n = 527 | Biliary Plastic Stent Removal (after One Year) n = 50 | p Value | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Gender: male, female | 278, 249 | 52.75%, 47.25% | 32, 18 | 64%, 36% | 0.127 |
| Age (years), (mean ± SD) | 51.76 ± 10.02 | 54.07 ± 7.70 | 0.113 | ||
| Indications of biliary plastic stenting | |||||
| Irretrievable CBD stones | 422 | 80.08% | 39 | 78% | 0.726 |
| Post-cholecystectomy biliary leak | 42 | 7.97% | 5 | 10% | 0.616 |
| Mirizzi syndrome | 48 | 9.11% | 4 | 8% | 0.794 |
| Benign CBD stricture | 15 | 2.85% | 2 | 4% | 0.860 |
| Stent stay (months), (mean ± SD) | 2.89 ± 0.31 | 29.09 ± 9.73 | 0.001 * | ||
| Presenting symptoms | |||||
| Jaundice | 9 | 1.71% | 46 | 92% | 0.001 * |
| Abdominal pain | 7 | 1.33% | 33 | 66% | 0.001 * |
| Fever | 4 | 0.76% | 17 | 34% | 0.001 * |
| Asymptomatic | 518 | 98.29% | 2 | 4% | 0.001 * |
3.3. Flow Chart of the Forgotten-Biliary-Plastic-Stent-Related Complications and Management
The flow chart revealed stent in situ (39 patients, 78%), distal stent migration (9 patients, 18%), and proximal stent migration (2 patients, 4%). Forty-four stents were retrieved (39 stents in situ, 3 accessible distally migrated stents, and 2 proximally migrated stents), and all of them were found to be clogged. Among these 44 patients, 23 patients had stent exchange, and 21 patients had CBD clearance. Furthermore, CBD clearance was achieved in the remaining 6 patients with distal stent migration (5 with undetected stents and 1 with an inaccessible stent) as illustrated in Figure 2.
3.4. Previous Studies and Case Reports of Forgotten Biliary Plastic Stents
The findings of previous studies and case reports of forgotten biliary plastic stents are summarized in Table 3.
| Authors | Year | Study Design | Patients | Stent Stay | Main Indication | Most Common | Management |
|---|---|---|---|---|---|---|---|
| (n) of Stenting Complications | |||||||
| Duman, A.E. [15] | 2021 | Retrospective | 48 | 22.5 months | CBD stones | Biliary stone formation | Endoscopic |
| Kumar, S. [10] | 2020 | Case report | 1 | 4 years | CBD stones | Giant Stentolith | Surgical |
| Kumar, S. [16] | 2017 | Retrospective | 21 | 3.53 years | CBD stones | Acute cholangitis | Surgical/Endoscopic |
| Sohn, S.H. [17] | 2017 | Retrospective | 38 | 22.6 ± 12.2 months | CBD stones | Acute cholangitis | Endoscopic |
| Barai, V. [18] | 2016 | Case report | 1 | 102 months | Benign CBD stricture | Cholangitic liver abscesses | Surgical |
| Patel, T.J. [19] | 2014 | Case report | 1 | 17 years | CBD stones | Perforated GB | Surgical |
4. Discussion
Biliary plastic stenting is a safe and broadly used treatment modality for short-term biliary decompression. However, long-term retained forgotten biliary stents can be hazardous. The forgotten biliary stents are often underestimated in clinical practice. Our study was performed to determine the forgotten-biliary-plastic-stent-related complications, their management, and the patients’ clinical outcomes.
Biliary plastic stents were deployed during the index ERCP for various benign biliary conditions. These stents were planned to be removed within 3 months of insertion to avoid possible complications related to prolonged stenting. These were in line with the studies of Perri et al. and Lawrence et al. [20,21].
In the current study, the main indication of biliary plastic stenting was irretrievable CBD stones in 422 patients, 80.08% (group 1), and in 39 patients, 78% (group 2). Our finding was in accordance with previous studies by Duman et al. and Taj et al.; they demonstrated that irretrievable CBD stones were the most common indication for biliary plastic stenting, accounting for 61% and 52.9% of their cases, respectively [14,22].
The mean duration of stent stay in patients with forgotten biliary plastic stents (group 2) was 29.09 ± 9.73 with a range of 13–46 months. It is worth noting that the most frequent reason for stents’ non-retrieval for extended periods is patients’ noncompliance with the endoscopists’ instructions. Patients’ unawareness of stent insertion or the need for its removal was another factor.
The incidence of biliary-plastic-stent-related complications (e.g., acute cholangitis, stent clogging, distal stent migration, new CBD stone formation, and proximal stent migration) was significantly higher in group 2 than in group 1. Acute cholangitis was found in 17 (34%) patients with forgotten biliary plastic stents. This is consistent with the findings of Duman et al. and Kumar et al.; they showed that cholangitis was frequently observed among their patients with higher percentages than ours (64.7%, and 66.6%, respectively) [15,16].
In patients with forgotten biliary stents, stent clogging was the most frequent encountered complication (44 patients, 88%), and this was in agreement with the work of Donelli et al., who showed that the major drawback of prolonged plastic stent placement was its tendency to clog [23]. Other complications included distal biliary stent migration (9 patients, 18%), new CBD stone formation (5 patients, 10%), and proximal biliary stent migration (2 patients, 4%). Duman et al. reported higher percentages of CBD stone formation (79%) and proximal stent migration (26.4%) in their patients than ours [15]. It was noted that 5 of 11 of our patients who previously had post-cholecystectomy biliary leak, Mirizzi syndrome, and CBD stricture were found to develop de novo CBD stones. In the remaining 39 patients who previously had irretrievable CBD stones, it was challenging to determine whether additional stones were newly developed alongside the previous ones or not. This could explain the lower percentage of new CBD stone formation in our study in comparison to those in other studies [15,16]. Therefore, new stone formation might be underestimated in the present study.
Stent clogging, CBD stone formation, and even acute cholangitis could be explained by duodenobiliary reflux, due to endoscopic sphincterotomy, and the retained biliary stent itself acting as a foreign body. These trigger bacterial colonization, biofilm formation, and calcium bilirubinate crystal deposition [24,25,26].
Nevertheless, two patients (4%) with forgotten biliary plastic stents were asymptomatic. This was consistent with the findings of Sohn et al., who stated that the biliary stent might remain in situ for years without causing any symptoms. Even a completely blocked stent might not disrupt bile flow because of the existence of additional pathways between the CBD wall and the stent [17].
Fortunately, in the present study, all biliary plastic stents and their related complications were successfully managed endoscopically, and there was no need for surgery or interventional radiology. This was in harmony with the finding of Duman et al. and Jaleel et al., who reported that all their patients were managed endoscopically [15,27]. On the other hand, surgical exploration for the management of stent-related complications was performed in 76.2% of the patients enrolled in Kumar et al.’s study [16]. The need for surgery could be attributable to the different complications encountered in their patients such as giant stentoliths and hepatolithiasis [16,18,28].
The laparoscopic cholecystectomy and CBD exploration are alternative treatments for choledocholithiasis in selected centers, particularly those with advanced laparoscopic surgeons. In this surgical intervention, a cholecystectomy and the removal of CBD stones are performed in a single step. Most importantly, sphincterotomy is avoided and there are no stents and possible further complications (e.g., acute pancreatitis, bleeding, and perforation) [29].
The limitations of the present study were its retrospective design. New CBD stone formation as a complication of forgotten biliary stents might have been underestimated in our study.
5. Conclusions
Based on this retrospective study, non-adherence to the endoscopists’ instructions is the main reason for retained biliary stents for a duration of more than one year. The forgotten stents had significantly higher complication rates, a higher number of endoscopic sessions, and a higher number of hospital admissions than those retrieved in accordance with the scheduled time. All patients were managed endoscopically with a technical success rate of 100%, with uneventful outcomes.
Recommendations: The patients who underwent ERCP with CBD stenting should be educated on having biliary stents, the scheduled date for stent removal, and the potential hazards of delaying removal. Giving appointment cards to the patients, as well as a short message service reminder, for scheduled stent removal is recommended to avoid stent-related undesirable outcomes. Calling patients that have not attended their scheduled appointments for stent removal is also considered. During ERCP reporting, we suggest to write the recommendation about biliary stent removal in both English and the patient’s native language to increase patients’ adherence to their subsequent ERCP appointments.
Abbreviations
| CBD | Common bile duct |
| ERCP | Endoscopic retrograde cholangiopancreatography |
| SPSS | Statistical Package for the Social Sciences |
| SD | Standard deviation |
Institutional Review Board Statement
The current study was approved by the local research ethical committee of the faculty of medicine, Tanta University, Egypt (approval code: 36264PR292/8/23, approval date: 9 August 2023), and conformed to the ethical principles for medical research of the Helsinki Declaration 1975 and its subsequent amendments (1983).
Informed Consent Statement
Informed consent was obtained from all patients involved in the study.
Data Availability Statement
Upon reasonable request, the data sets used in the current study are available from the corresponding author.
Conflicts of Interest
The authors declare no conflicts of interest.
Funding Statement
This research received no external funding.
Footnotes
Footnote Group
References
Untitled section
References
- 1.Boicean A., Birlutiu V., Ichim C., Todor S.B., Hasegan A., Bacila C., Solomon A., Cristian A., Dura H. Predictors of post-ERCP pancreatitis (P.E.P.) in choledochal lithiasis extraction. J. Pers. Med. 2023;13:1356. doi: 10.3390/jpm13091356.
- 2.Yang J., Peng J.Y., Chen W. Endoscopic biliary stenting for irretrievable common bile duct stones: Indications, advantages, disadvantages, and follow-up results. Surgeon. 2012;10:211–217. doi: 10.1016/j.surge.2012.04.003.
- 3.Rustagi T., Aslanian H.R. Endoscopic management of biliary leaks after laparoscopic cholecystectomy. J. Clin. Gastroenterol. 2014;48:674–678. doi: 10.1097/MCG.0000000000000044.
- 4.Ye X., Huai J., Sun X. Effectiveness and safety of biliary stenting in the management of difficult common bile duct stones in elderly patients. Turk. J. Gastroenterol. 2016;27:30–36. doi: 10.5152/tjg.2015.150305.
- 5.Khashab M.A., Kim K., Hutfless S., Lennon A.M., Kalloo A.N., Singh V.K. Predictors of early stent occlusion among plastic biliary stents. Dig. Dis. Sci. 2012;57:2446–2450. doi: 10.1007/s10620-012-2178-4.
- 6.Vaishnavi C., Samanta J., Kochhar R. Characterization of biofilms in biliary stents and potential factors involved in occlusion. World. J. Gastroenterol. 2018;24:112–123. doi: 10.3748/wjg.v24.i1.112.
- 7.Schneider J., Hapfelmeier A., Fremd J., Schenk P., Obermeier A., Burgkart R., Forkl S., Feihl S., Wantia N., Neu B., et al. Biliary endoprosthesis: A prospective analysis of bacterial colonization and risk factors for sludge formation. PLoS ONE. 2014;9:e110112. doi: 10.1371/journal.pone.0110112.
- 8.Dumonceau J.M., Tringali A., Papanikolaou I.S., Blero D., Mangiavillano B., Schmidt A., Vanbiervliet G., Costamagna G., Devière J., García-Cano J., et al. Endoscopic biliary stenting: Indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline—Updated October. Endoscopy. 2018;50:910–930. doi: 10.1055/a-0659-9864.
- 9.Dumonceau J.M., Tringali A., Blero D., Devière J., Laugiers R., Heresbach D., Costamagna G. Biliary stenting: Indications, choice of stents and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:277–298. doi: 10.1055/s-0031-1291633.
- 10.Kumar S., Chandra A. Giant stentolith: A rare complication of long-dwelling biliary endoprosthesis. Arab. J. Gastroenterol. 2020;21:132–134. doi: 10.1016/j.ajg.2020.04.008.
- 11.Poushanchi B., Hsueh W., Nasr J. Cholangioscopic forceps-assisted retrieval of a forgotten biliary stent through a distal biliary stricture. VideoGIE. 2018;3:349–350. doi: 10.1016/j.vgie.2018.07.016.
- 12.Odabasi M., Arslan C., Akbulut S., Abuoglu H.H., Ozkan E., Yildiz M.K., Eris C., Gunay E., Tekesin K., Muftuoglu T. Long-term effects of forgotten biliary stents: A case series and literature review. Int. J. Clin. Exp. Med. 2014;7:2045–2052.
- 13.Kiriyama S., Kozaka K., Takada T., Strasberg S.M., Pitt H.A., Gabata T., Hata J., Liau K.-H., Miura F., Horiguchi A., et al. Tokyo Guidelines 2018: Diagnostic criteria and severity grading of acute cholangitis. J. Hepato-Biliary-Pancreat. Sci. 2018;25:17–30. doi: 10.1002/jhbp.512.
- 14.Duman A.E., Hulagu S. Management of migrated plastic biliary stents in patients with benign biliary diseases. Laparosc. Endosc. Surg. Sci. 2022;29:29–35. doi: 10.14744/less.2022.95777.
- 15.Duman A.E., Yilmaz H., Hulagu S. Biliary stents are forgotten more frequently in elderly patients. Turk. J. Med. Sci. 2021;51:3067–3072. doi: 10.3906/sag-2104-108.
- 16.Kumar S., Chandra A., Kulkarni R., Maurya A.P., Gupta V. Forgotten biliary stents: Ignorance is not bliss. Surg. Endosc. 2017;32:191–195. doi: 10.1007/s00464-017-5657-z.
- 17.Sohn S.H., Park J.H., Kim K.H., Kim T.N. Complications and management of forgotten long-term biliary stents. World J. Gastroenterol. 2017;23:622–628. doi: 10.3748/wjg.v23.i4.622.
- 18.Baraia V., Hedawoob J., Changole S. Forgotten CBD stent (102 months) with stone-stent complex: A case report. Int. J. Surg. Case Rep. 2017;30:162–164. doi: 10.1016/j.ijscr.2016.11.048.
- 19.Patel T.J., Rajput S., Patel K.S., Haribhakti S.P. A forgotten biliary stent for 17 years: Presented with perforated gallbladder and stentolith. J. Dig. Endosc. 2014;5:22–23. doi: 10.4103/0976-5042.141931.
- 20.Perri V., Familiari P., Tringali A., Boskoski I., Costamagna G. Plastic biliary stents for benign biliary diseases. Gastrointest. Endosc. Clin. N. Am. 2011;21:405–433. doi: 10.1016/j.giec.2011.04.012.
- 21.Lawrence C., Romagnuolo J., Payne K.M., Hawes R.H., Cotton P.B. Low symptomatic premature stent occlusion of multiple plastic stents for benign biliary strictures: Comparing standard and prolonged stent change intervals. Gastrointest. Endosc. 2010;72:558–563. doi: 10.1016/j.gie.2010.05.029.
- 22.Taj M.A., Ghazanfar S., Qureshi S., Zubair M., Niaz S.K., Quraishy M.S. Plastic stent migration in ERCP; a tertiary care experience. JPMA. 2019;69:1099–1102.
- 23.Donelli G., Guaglianone E., Di Rosa R., Fiocca F., Basoli A. Plastic biliary stent occlusion: Factors involved and possible preventive approaches. Clin. Med. Res. 2007;5:53–60. doi: 10.3121/cmr.2007.683.
- 24.Tohda G., Dochin M. Management of endoscopic biliary stenting for choledocholithiasis: Evaluation of stent exchange intervals. World. J. Gastrointest. Endosc. 2018;10:45. doi: 10.4253/wjge.v10.i1.45.
- 25.Weickert U., Venzke T., König J., Janssen J., Remberger K., Greiner L. Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy. 2001;33:786–790. doi: 10.1055/s-2001-16519.
- 26.Guaglianone E., Cardines R., Vuotto C., Di Rosa R., Babini V., Mastrantonio P., Donelli G. Microbial biofilms associated with biliary stent clogging. FEMS. Immunol. Med. Microbiol. 2010;59:410–420. doi: 10.1111/j.1574-695X.2010.00686.x.
- 27.Jaleel R., Simon E.G., Gupta P., Patnaik I., David D., Chowdhury S.D. Retained biliary plastic stents—Lest we forget. Trop. Dr. 2021;51:177–180. doi: 10.1177/0049475520945443.
- 28.Bansal V.K., Misra M.C., Bhowate P., Kumar S. Laparoscopic management of common bile duct “Stentolith”. Trop. Gastroenterol. 2009;30:95–96.
- 29.Pogorelić Z., Lovrić M.J., Jukić M., Perko Z. The Laparoscopic Cholecystectomy and Common Bile Duct Exploration. A Single-Step Treatment of Pediatric Cholelithiasis and Choledocholithiasis. Children. 2022;19:1583. doi: 10.3390/children9101583.
Associated Data
Data Availability Statement
Upon reasonable request, the data sets used in the current study are available from the corresponding author.